Leila A. Mankarious, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cricoid Cartilage | 10 | 2010 | 69 | 2.180 |
Why?
|
| Hearing Loss, Sensorineural | 5 | 2022 | 783 | 1.230 |
Why?
|
| Hearing Loss | 4 | 2022 | 786 | 1.050 |
Why?
|
| Deafness | 2 | 2022 | 462 | 0.850 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2022 | 25 | 0.780 |
Why?
|
| Thyroglossal Cyst | 2 | 2011 | 31 | 0.690 |
Why?
|
| Language Development Disorders | 1 | 2020 | 193 | 0.620 |
Why?
|
| Transforming Growth Factor beta3 | 2 | 2008 | 45 | 0.610 |
Why?
|
| Cochlear Implantation | 4 | 2022 | 319 | 0.610 |
Why?
|
| Motor Skills | 1 | 2020 | 523 | 0.550 |
Why?
|
| Cytomegalovirus Infections | 1 | 2022 | 839 | 0.490 |
Why?
|
| Chondrocytes | 6 | 2008 | 800 | 0.480 |
Why?
|
| Glottis | 3 | 2006 | 214 | 0.460 |
Why?
|
| Salivary Glands | 2 | 2011 | 231 | 0.400 |
Why?
|
| POU Domain Factors | 1 | 2010 | 47 | 0.360 |
Why?
|
| Hearing | 3 | 2022 | 502 | 0.360 |
Why?
|
| Maxillofacial Development | 1 | 2010 | 88 | 0.350 |
Why?
|
| Respiratory System | 2 | 2010 | 565 | 0.340 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2003 | 835 | 0.340 |
Why?
|
| Laryngitis | 1 | 2009 | 27 | 0.330 |
Why?
|
| Larynx | 2 | 2010 | 492 | 0.290 |
Why?
|
| Immunoglobulin A | 1 | 2011 | 991 | 0.280 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2010 | 386 | 0.270 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 462 | 0.270 |
Why?
|
| Connective Tissue | 1 | 2008 | 425 | 0.270 |
Why?
|
| Saliva | 1 | 2011 | 854 | 0.260 |
Why?
|
| Skull | 1 | 2010 | 831 | 0.250 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2008 | 633 | 0.250 |
Why?
|
| Collagen Type II | 2 | 2003 | 151 | 0.240 |
Why?
|
| Drainage | 1 | 2011 | 1183 | 0.240 |
Why?
|
| Immunohistochemistry | 9 | 2011 | 11117 | 0.230 |
Why?
|
| Otoscopy | 2 | 2021 | 40 | 0.220 |
Why?
|
| Registries | 1 | 2020 | 8378 | 0.220 |
Why?
|
| Epithelium | 1 | 2008 | 1609 | 0.220 |
Why?
|
| Child, Preschool | 17 | 2022 | 42654 | 0.210 |
Why?
|
| Proteoglycans | 2 | 2003 | 807 | 0.200 |
Why?
|
| Cognition | 1 | 2020 | 7074 | 0.200 |
Why?
|
| Electronic Health Records | 1 | 2020 | 4874 | 0.200 |
Why?
|
| Aggrecans | 3 | 2010 | 89 | 0.190 |
Why?
|
| Cartilage | 2 | 2002 | 811 | 0.180 |
Why?
|
| Vestibular Aqueduct | 1 | 2021 | 73 | 0.180 |
Why?
|
| Tracheal Stenosis | 1 | 2002 | 228 | 0.170 |
Why?
|
| Cochlear Implants | 2 | 2022 | 343 | 0.170 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2020 | 210 | 0.160 |
Why?
|
| Respiration Disorders | 1 | 2002 | 366 | 0.160 |
Why?
|
| Sialorrhea | 1 | 1999 | 25 | 0.160 |
Why?
|
| Ibuprofen | 1 | 2021 | 229 | 0.160 |
Why?
|
| Otitis Media | 1 | 2021 | 288 | 0.160 |
Why?
|
| Otologic Surgical Procedures | 1 | 2020 | 150 | 0.160 |
Why?
|
| Submandibular Gland | 1 | 1999 | 85 | 0.160 |
Why?
|
| Collagen Type I | 1 | 2002 | 620 | 0.160 |
Why?
|
| Animals, Newborn | 3 | 2010 | 2695 | 0.150 |
Why?
|
| Ear Diseases | 1 | 2020 | 181 | 0.150 |
Why?
|
| Wound Healing | 3 | 2009 | 2812 | 0.150 |
Why?
|
| Intubation, Intratracheal | 2 | 2003 | 1359 | 0.150 |
Why?
|
| Dermoid Cyst | 1 | 1998 | 92 | 0.150 |
Why?
|
| Speech Perception | 1 | 2022 | 512 | 0.140 |
Why?
|
| Tonsillectomy | 1 | 2021 | 280 | 0.140 |
Why?
|
| Automation | 1 | 2020 | 588 | 0.140 |
Why?
|
| Aging | 2 | 2009 | 8764 | 0.140 |
Why?
|
| Child | 16 | 2022 | 80894 | 0.140 |
Why?
|
| Nose Neoplasms | 1 | 1998 | 250 | 0.130 |
Why?
|
| Organ Culture Techniques | 2 | 2010 | 796 | 0.130 |
Why?
|
| Pilot Projects | 5 | 2021 | 8730 | 0.120 |
Why?
|
| Auditory Perception | 1 | 2020 | 588 | 0.120 |
Why?
|
| Ear, External | 1 | 1996 | 165 | 0.120 |
Why?
|
| Postoperative Period | 2 | 2011 | 1830 | 0.120 |
Why?
|
| Intelligence | 1 | 2020 | 929 | 0.120 |
Why?
|
| Laryngeal Mucosa | 2 | 2006 | 32 | 0.120 |
Why?
|
| Replantation | 1 | 1996 | 145 | 0.120 |
Why?
|
| Rhinoplasty | 1 | 1998 | 241 | 0.120 |
Why?
|
| Rabbits | 3 | 2009 | 4782 | 0.120 |
Why?
|
| Amputation, Traumatic | 1 | 1996 | 135 | 0.120 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 562 | 0.120 |
Why?
|
| Physical Examination | 1 | 2020 | 1262 | 0.110 |
Why?
|
| Apoptosis | 3 | 2010 | 9506 | 0.110 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2008 | 610 | 0.110 |
Why?
|
| Cytokines | 1 | 2009 | 7443 | 0.110 |
Why?
|
| Analgesics | 1 | 2020 | 1070 | 0.110 |
Why?
|
| Pain, Postoperative | 2 | 2021 | 1764 | 0.110 |
Why?
|
| Cochlea | 1 | 2019 | 845 | 0.110 |
Why?
|
| Telemedicine | 2 | 2021 | 3107 | 0.110 |
Why?
|
| Infant | 10 | 2021 | 36512 | 0.100 |
Why?
|
| Temporal Bone | 2 | 2018 | 683 | 0.090 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2003 | 287 | 0.090 |
Why?
|
| Endoscopy | 1 | 2020 | 1856 | 0.090 |
Why?
|
| Retrospective Studies | 9 | 2022 | 81768 | 0.090 |
Why?
|
| Microsurgery | 1 | 1996 | 803 | 0.090 |
Why?
|
| Audiometry | 1 | 2010 | 253 | 0.090 |
Why?
|
| Hearing Tests | 2 | 2022 | 123 | 0.080 |
Why?
|
| Lectins, C-Type | 2 | 2003 | 591 | 0.080 |
Why?
|
| alpha-Amylases | 1 | 2009 | 39 | 0.080 |
Why?
|
| Hyoid Bone | 1 | 2009 | 38 | 0.080 |
Why?
|
| Adolescent | 13 | 2021 | 89182 | 0.080 |
Why?
|
| Salivary Proteins and Peptides | 1 | 2009 | 48 | 0.080 |
Why?
|
| Mucin 5AC | 1 | 2009 | 96 | 0.080 |
Why?
|
| Respiratory System Abnormalities | 1 | 2009 | 67 | 0.080 |
Why?
|
| Dipeptides | 1 | 2010 | 386 | 0.070 |
Why?
|
| Humans | 27 | 2022 | 768298 | 0.070 |
Why?
|
| Smad2 Protein | 1 | 2008 | 144 | 0.070 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 393 | 0.070 |
Why?
|
| Ear, Inner | 1 | 2011 | 426 | 0.070 |
Why?
|
| Protease Inhibitors | 1 | 2010 | 752 | 0.070 |
Why?
|
| Cell Count | 2 | 2000 | 1833 | 0.070 |
Why?
|
| Elastic Tissue | 1 | 2006 | 66 | 0.070 |
Why?
|
| Mutation | 1 | 2010 | 30230 | 0.060 |
Why?
|
| Software | 1 | 2020 | 4452 | 0.060 |
Why?
|
| Mucins | 1 | 2009 | 571 | 0.060 |
Why?
|
| Follow-Up Studies | 4 | 2011 | 39405 | 0.060 |
Why?
|
| Animals | 9 | 2010 | 169322 | 0.060 |
Why?
|
| Cell Division | 2 | 2003 | 4478 | 0.060 |
Why?
|
| Respiratory Tract Diseases | 1 | 2009 | 748 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3811 | 0.050 |
Why?
|
| Orbital Pseudotumor | 1 | 2003 | 42 | 0.050 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2003 | 142 | 0.050 |
Why?
|
| Bionics | 1 | 2022 | 46 | 0.050 |
Why?
|
| Fetus | 2 | 2000 | 1883 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3118 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3241 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 2636 | 0.050 |
Why?
|
| Mice | 4 | 2010 | 82004 | 0.050 |
Why?
|
| Otitis | 1 | 2000 | 21 | 0.050 |
Why?
|
| Trauma Severity Indices | 1 | 2002 | 479 | 0.050 |
Why?
|
| Tympanic Membrane Perforation | 1 | 2020 | 45 | 0.040 |
Why?
|
| Cholesteatoma, Middle Ear | 1 | 2020 | 52 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 2000 | 239 | 0.040 |
Why?
|
| Methicillin Resistance | 1 | 2000 | 198 | 0.040 |
Why?
|
| Tympanic Membrane | 1 | 2021 | 232 | 0.040 |
Why?
|
| Adenoidectomy | 1 | 2021 | 170 | 0.040 |
Why?
|
| Laryngostenosis | 1 | 2000 | 168 | 0.040 |
Why?
|
| Respiratory Sounds | 1 | 2002 | 702 | 0.040 |
Why?
|
| Age Factors | 3 | 2011 | 18472 | 0.040 |
Why?
|
| Postoperative Hemorrhage | 1 | 2021 | 418 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2008 | 8326 | 0.030 |
Why?
|
| Esthetics | 1 | 1998 | 330 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 18358 | 0.030 |
Why?
|
| Leeches | 1 | 1996 | 11 | 0.030 |
Why?
|
| Infant, Newborn | 4 | 2021 | 26410 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2000 | 2474 | 0.030 |
Why?
|
| Neuromuscular Diseases | 1 | 1999 | 261 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2000 | 1972 | 0.030 |
Why?
|
| Pediatrics | 1 | 2009 | 3624 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2009 | 3464 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 20224 | 0.030 |
Why?
|
| Regeneration | 1 | 2002 | 1525 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2000 | 2204 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2000 | 1739 | 0.030 |
Why?
|
| Male | 10 | 2020 | 364870 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2000 | 1428 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2008 | 10464 | 0.020 |
Why?
|
| Collagen | 1 | 2000 | 2646 | 0.020 |
Why?
|
| Reoperation | 1 | 2022 | 4340 | 0.020 |
Why?
|
| Quality of Life | 1 | 2013 | 13499 | 0.020 |
Why?
|
| Gestational Age | 1 | 2000 | 3615 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2020 | 65365 | 0.020 |
Why?
|
| Pandemics | 2 | 2021 | 8750 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2000 | 6319 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2020 | 3579 | 0.020 |
Why?
|
| Female | 9 | 2020 | 397050 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2011 | 20766 | 0.020 |
Why?
|
| Postoperative Care | 1 | 1996 | 1479 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 1 | 2003 | 2923 | 0.020 |
Why?
|
| Time Factors | 2 | 2020 | 40267 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2009 | 794 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10588 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 14783 | 0.020 |
Why?
|
| Graft Survival | 1 | 1996 | 3900 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2018 | 3587 | 0.010 |
Why?
|
| Models, Animal | 1 | 2009 | 2124 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2000 | 9261 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1999 | 15455 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2000 | 7458 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 1999 | 15939 | 0.010 |
Why?
|
| Mastoiditis | 1 | 2000 | 38 | 0.010 |
Why?
|
| Anticoagulants | 1 | 1996 | 4842 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 41791 | 0.010 |
Why?
|
| Community-Acquired Infections | 1 | 2000 | 473 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1999 | 15854 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2000 | 2226 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 3541 | 0.010 |
Why?
|
| Adult | 2 | 2002 | 223622 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2011 | 22292 | 0.010 |
Why?
|
| Risk Factors | 1 | 1999 | 74954 | 0.010 |
Why?
|
| Middle Aged | 1 | 2002 | 223463 | 0.000 |
Why?
|
| United States | 1 | 2009 | 73144 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 36849 | 0.000 |
Why?
|